Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Behavioural Brain Research

• Publication date

  2014-08-15

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1016/j.bbr.2014.05.029PMID 24867330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse

  2014cited by this paper
• Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates.

  2014cited by this paper
• The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently.

  2013cited by this paper
• Modulation of the Endocannabinoid System: Vulnerability Factor and New Treatment Target for Stimulant Addiction

  2013influential reference
• Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies.

  2012cited by this paper
• Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation.

  2012cited by this paper
• Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

  2011cited by this paper
• Brain Cannabinoid CB2 Receptors Modulate Cocaine’s Actions in Mice

  2011cited by this paper
• Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.

  2010cited by this paper
• Bimodal control of stimulated food intake by the endocannabinoid system

  2010cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

  2010cited by this paper
• CB2: a cannabinoid receptor with an identity crisis

  2010cited by this paper
• CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: role of mGlu5 receptors.

  2009cited by this paper
• Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure.

  2009cited by this paper
• Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice

  2009cited by this paper
• Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion‐induced dopamine dysregulation

  2009cited by this paper
• Frequency-Dependent Inversion of Net Striatal Output by Endocannabinoid-Dependent Plasticity at Different Synaptic Inputs

  2009cited by this paper
• Individual responses to novelty are associated with differences in behavioral and neurochemical profiles.

  2008cited by this paper
• The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization.

  2008cited by this paper
• Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals

  2008cited by this paper
• The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus.

  2008cited by this paper
• Phasic Dopamine Release Evoked by Abused Substances Requires Cannabinoid Receptor Activation

  2007cited by this paper
• Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants

  2007cited by this paper
• Analogs of SR-141716A (Rimonabant) alter d-amphetamine-evoked [3H] dopamine overflow from preloaded striatal slices and amphetamine-induced hyperactivity.

  2007cited by this paper
• Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum

  2007cited by this paper
• Involvement of cannabinoid CB1 and CB2 receptor activity in the development of behavioural sensitization to methamphetamine effects in mice.

  2006cited by this paper
• Cannabinoid CB1 Receptor Antagonist AM251 Inhibits Cocaine-Primed Relapse in Rats: Role of Glutamate in the Nucleus Accumbens

  2006cited by this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cited by this paper
• Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration

  2005cited by this paper
• Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.

  2005cited by this paper
• Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis

  2005cited by this paper
• CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 Receptors

  2005cited by this paper
• WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function.

  2005cited by this paper
• A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic Transmission

  2004cited by this paper
• The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

  2003cited by this paper
• Differential Regulation of the Endocannabinoids Anandamide and 2-Arachidonylglycerol within the Limbic Forebrain by Dopamine Receptor Activity

  2003cited by this paper
• Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats.

  2002cited by this paper
• Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study

  2002cited by this paper
• The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.

  2001cited by this paper
• Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens

  2001cited by this paper
• Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse.

  2001cited by this paper
• Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction.

  2001cited by this paper
• Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice

  2000cited by this paper
• Dependence of mesolimbic dopamine transmission on Δ9-tetrahydrocannabinol

  1999cited by this paper
• Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.

  1999cited by this paper
• Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

  1999cited by this paper
• Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.

  1999cited by this paper
• Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests.

  1999cited by this paper
• D-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats.

  1998cited by this paper
• Biphasic effects of anandamide.

  1998cited by this paper
• Differential alterations in basal and D-amphetamine-induced behavioural pattern following 6-OHDA or ibotenic acid lesions into the dorsal striatum.

  1998cited by this paper
• Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.

  1995cited by this paper
• Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

  1991cited by this paper
• Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

  1990cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats

  2024cites this paper
• Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study

  2022cites this paper
• Endocannabinoids and addiction memory: Relevance to methamphetamine/morphine abuse

  2022cites this paper
• Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats

  2021cites this paper
• Dehydroepiandrosterone increases tonic and phasic dopamine release in the striatum.

  2020cites this paper
• Adolescent Exposure to WIN 55212-2 Render the Nigrostriatal Dopaminergic Pathway Activated During Adulthood

  2020cites this paper
• Suppressing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on locomotor hyperactivity induced by different drugs of abuse.

  2020cites this paper
• Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity

  2019cites this paper
• Comparing dopaminergic dynamics in the dorsolateral striatum between adolescent and adult rats: Effect of an acute dose of WIN55212-2.

  2019cites this paper
• Biological bases for a possible effect of cannabidiol in Parkinson’s disease

  2019cites this paper
• Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia

  2019cites this paper
• Attenuation Effect of Cannabinoid Type 1 Receptor Activation on Methamphetamine-Induced Neurodegeneration and Locomotion Impairments among Male Rats

  2017cites this paper
• The Impact of Cannabinoids on Motor Activity and Neurochemical Correlates

  2017cites this paper
• A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus—A case report and review of the literature

  2017cites this paper
• Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity

  2016cites this paper
• Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats

  2016cites this paper
• Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment.

  2016cites this paper
• Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

  2016cites this paper
• Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis

  2015cites this paper
• Cannabinoïdes de synthèse : aspects pharmacologiques

  2015cites this paper